Literature DB >> 1597209

A new report of triclabendazole efficacy during invading phase fasciolasis.

S Picot, M Querrec, J L Ghez, A Goullier-Fleuret, R Grillot, P Ambroise-Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1597209     DOI： 10.1007/bf02098098

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  4 in total

1.  Comparative efficacy of triclabendazole, nitroxynil and rafoxanide against immature and mature Fasciola hepatica in naturally infected cattle.

Authors:  D Rapic; N Dzakula; D Sakar; R J Richards
Journal:  Vet Rec       Date:  1988-01-16       Impact factor: 2.695

2.  Anthelmintic activity of triclabendazole.

Authors:  G C Coles
Journal:  J Helminthol       Date:  1986-09       Impact factor: 2.170

3.  [Fasciola hepatica infection. Successful therapy using triclabendazole].

Authors:  K Markwalder; M Koller; N Goebel; K Wolff
Journal:  Schweiz Med Wochenschr       Date:  1988-07-12

4.  Human fascioliasis treated with triclabendazole (Fasinex) for the first time.

Authors:  K Wessely; H L Reischig; M Heinerman; R Stempka
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184
  4 in total
  1 in total

1.  Acute Fasciola hepatica infection attributed to chewing khat.

Authors:  A Cats; P Scholten; S G Meuwissen; E J Kuipers
Journal:  Gut       Date:  2000-10       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.